<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03080454</url>
  </required_header>
  <id_info>
    <org_study_id>15-110</org_study_id>
    <nct_id>NCT03080454</nct_id>
  </id_info>
  <brief_title>The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke</brief_title>
  <official_title>The Effect of Treatment With the PathMaker Myoregulator Neuromodulation System Incorporating Trans-spinal Direct Current Stimulation (tsDCS) in Patients With Severe Hand Spasticity After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PathMaker Neurosystems Inc</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. Zaghloul Ahmed</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate if 5 consecutive sessions of PathMaker DoubleStim
      treatment, which combines non-invasive stimulation of the spinal cord (tsDCS- trans-spinal
      direct current stimulation) and of the median nerve at the peripheral wrist (pDCS--
      peripheral direct current stimulation), can significantly reduce spasticity of the wrist and
      hand after stroke.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Instrumental assessment of muscle tone</measure>
    <time_frame>Conditions 1 &amp; 2: change from baseline at day 3 and 5 of stimulation, and at follow-up weeks 1-4</time_frame>
    <description>objective assessment of passive muscle resistance with a force transducer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tardieu Scale</measure>
    <time_frame>Conditions 1 &amp; 2: change from baseline at day 3 and 5 of stimulation, and at follow-up weeks 1-4</time_frame>
    <description>Clinical assessment of spasticity of the upper extremity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">23</enrollment>
  <condition>Stroke</condition>
  <condition>CVA</condition>
  <condition>Hemiparesis</condition>
  <condition>Spasticity as Sequela of Stroke</condition>
  <condition>Muscle Spasticity</condition>
  <condition>Upper Extremity Paralysis</condition>
  <arm_group>
    <arm_group_label>Doublestim anodal stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Doublestim sham stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pathmaker MyoRegulator neuromodulation system</intervention_name>
    <arm_group_label>Doublestim anodal stimulation</arm_group_label>
    <arm_group_label>Doublestim sham stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. First single focal unilateral hemisphere lesion with diagnosis verified by brain
             imaging (MRI or CT scans) that occurred at least 6 months prior

          2. Cognitive function sufficient to understand the experiments and follow instructions

          3. A Modified Ashworth score between 1-3 points for wrist flexors and extensor muscles

          4. A minimum of 15 degrees wrist passive ROM for wrist flexion and extension from wrist
             neutral position

        Exclusion Criteria:

          1. Focal brainstem or thalamic infarcts

          2. Prior surgical treatments for spasticity of the upper limb

          3. Ongoing use of CNS-active medications

          4. Ongoing use of psychoactive medications, such as stimulants, antidepressants, and
             anti-psychotic medications

          5. Botox or phenal alcohol treatment within 12 weeks of enrollment

          6. Pregnancy in women, as determined by self-report

          7. History of spinal cord injury or weakness

          8. Chronic pain

          9. Peripheral neuropathy including insulin dependent diabetes as determined by case
             history

         10. Presence of additional potential tsDCS risk factors:

               -  Damaged skin at the site of stimulation (i.e., skin with ingrown hairs, acne,
                  razor nicks, wounds that have not healed recent scar tissue, broken skin, etc.)

               -  Presence of an electrically, magnetically or mechanically activated implant
                  (including cardiac pacemaker), an intracerebral vascular clip, or any other
                  electrically sensitive support system

               -  Highly conductive metal in any part of the body, including metal injury to the
                  eye (jewelry must be removed during stimulation)

               -  Past history of seizures or unexplained spells of loss of consciousness during
                  the previous 36 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Feinstein Institute for Medical Research</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ahmed Z. Trans-spinal direct current stimulation alters muscle tone in mice with and without spinal cord injury with spasticity. J Neurosci. 2014 Jan 29;34(5):1701-9. doi: 10.1523/JNEUROSCI.4445-13.2014.</citation>
    <PMID>24478352</PMID>
  </reference>
  <reference>
    <citation>Ahmed Z. Trans-spinal direct current stimulation modifies spinal cord excitability through synaptic and axonal mechanisms. Physiol Rep. 2014 Sep 28;2(9). pii: e12157. doi: 10.14814/phy2.12157. Print 2014 Sep 1.</citation>
    <PMID>25263206</PMID>
  </reference>
  <reference>
    <citation>Samaddar S, Vazquez K, Ponkia D, Toruno P, Sahbani K, Begum S, Abouelela A, Mekhael W, Ahmed Z. Transspinal direct current stimulation modulates migration and proliferation of adult newly born spinal cells in mice. J Appl Physiol (1985). 2017 Feb 1;122(2):339-353. doi: 10.1152/japplphysiol.00834.2016. Epub 2016 Dec 8.</citation>
    <PMID>27932680</PMID>
  </reference>
  <reference>
    <citation>Winkler T, Hering P, Straube A. Spinal DC stimulation in humans modulates post-activation depression of the H-reflex depending on current polarity. Clin Neurophysiol. 2010 Jun;121(6):957-61. doi: 10.1016/j.clinph.2010.01.014. Epub 2010 Feb 11.</citation>
    <PMID>20153248</PMID>
  </reference>
  <reference>
    <citation>Bocci T, Vannini B, Torzini A, Mazzatenta A, Vergari M, Cogiamanian F, Priori A, Sartucci F. Cathodal transcutaneous spinal direct current stimulation (tsDCS) improves motor unit recruitment in healthy subjects. Neurosci Lett. 2014 Aug 22;578:75-9. doi: 10.1016/j.neulet.2014.06.037. Epub 2014 Jun 23.</citation>
    <PMID>24970753</PMID>
  </reference>
  <reference>
    <citation>Truini A, Vergari M, Biasiotta A, La Cesa S, Gabriele M, Di Stefano G, Cambieri C, Cruccu G, Inghilleri M, Priori A. Transcutaneous spinal direct current stimulation inhibits nociceptive spinal pathway conduction and increases pain tolerance in humans. Eur J Pain. 2011 Nov;15(10):1023-7. doi: 10.1016/j.ejpain.2011.04.009. Epub 2011 May 14.</citation>
    <PMID>21576030</PMID>
  </reference>
  <reference>
    <citation>Cogiamanian F, Vergari M, Pulecchi F, Marceglia S, Priori A. Effect of spinal transcutaneous direct current stimulation on somatosensory evoked potentials in humans. Clin Neurophysiol. 2008 Nov;119(11):2636-40. doi: 10.1016/j.clinph.2008.07.249. Epub 2008 Sep 10.</citation>
    <PMID>18786856</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2017</study_first_submitted>
  <study_first_submitted_qc>March 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2017</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwell Health</investigator_affiliation>
    <investigator_full_name>Bruce Volpe</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>CVA</keyword>
  <keyword>Spasticity</keyword>
  <keyword>hemiparesis</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>tsDCS</keyword>
  <keyword>non-invasive stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Paresis</mesh_term>
    <mesh_term>Hemiplegia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

